2 completed, 1 not yet recruiting. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Not applicable | 1 | Completed 1 |
Follow Nicotinamide Adenine Dinucleotide: new trials by email Literature Review of Nicotinamide Adenine Dinucleotide trials Research Report on Nicotinamide Adenine Dinucleotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PEDIatric Cardiac Dysfunction Treated With Injectable Nicotinamide Adenine Dinucleotide Placebo, Nicotinamide Adenine Dinucleotide - Cardiac Dysfunction | Phase 2 | Not yet recruiting | Beijing Children's Hospital | 180 | 2026-10-01 | 2026-09-24 |
| NAD+ Oral Supplement Pilot Intervention in Adult Females Treatment, Placebo - Cognitive Change, Inflammation | Not applicable | Completed | University of Rhode Island | 53 | 2024-12-01 | 2026-03-12 |
| Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome Naltrexone, NAD+ - Covid19, Long COVID-19 | Phase 2 | Completed | AgelessRx | 36 | 2021-01-28 | 2023-01-25 |
COVID-19 (1) · Inflammation (1) · Neurodegenerative Diseases (1) · Post-Acute COVID-19 Syndrome (1)
AgelessRx (1) · Beijing Children's Hospital (1) · University of Rhode Island (1)
United States (2) · China (1)
P20GM103430 (1)